Rx (Prescription Medicine)
USD $ 120.00
Celtere 120mg 注射剂是一种关键药物，用于管理特定的医学病症。其活性成分 Denosumab 是一种人源单克隆抗体，可抑制破骨细胞的活性，而破骨细胞是负责骨吸收的细胞。通过减少骨质流失，Celtere 有助于提高骨密度和骨强度，从而降低骨折及其他骨相关并发症的风险。
Celtere 120mg 注射剂的适应症包括与某些癌症相关的骨质流失，如固体肿瘤转移至骨骼及多发性骨髓瘤，以及用于高风险骨折的绝经后妇女的骨质疏松。它还用于正在接受雄激素剥夺疗法的晚期前列腺癌患者，以预防骨相关不良事件。
Celtere 120mg 注射剂的典型剂量和给药方案应由医疗专业人员根据患者的个体情况和治疗反应确定。常见的不良反应可能包括低钙血症、肌肉骨骼疼痛、疲劳以及胃肠道不适。在使用本药物前，请务必告知医生您是否有既往疾病，尤其是肾功能问题或低钙血症。正确的储存条件通常为常温并避光，需遵照药品生产厂家的说明进行。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
其他品牌的 Docetaxel 120 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
